ALEXION PHARMACEUTICALS INC.

In News

Alexion Pharmaceuticals discloses C1S inhibitors - BioWorld News

BioWorld News - Jan 16, 2026

Alexion Beats Trade Secret Claims In Amyndas Suit - Law360

Law360 - Apr 02, 2026

Alexion Securities Class Action Lawsuit - Settlement - Motley Rice

Motley Rice - Nov 05, 2025

AstraZeneca drug acquired in Alexion deal succeeds in autoimmune disease trial - BioPharma Dive

BioPharma Dive - Jul 24, 2025

Alexion, AstraZeneca Rare Disease reaches an agreement with the pan-Canadian Pharmaceutical Alliance (pCPA) for Ultomiris for the treatment of adults with neuromyelitis optica spectrum disorder (NMOSD) and adults with generalized myasthenia gravis (g - Yahoo Finance

Yahoo Finance - Aug 07, 2025

JCR Pharmaceuticals Enters License Agreement with Alexion for Proprietary JUST-AAV Capsids to be Used in the Development of Genomic Medicines - BioSpace

BioSpace - Jul 08, 2025

Geographic Atrophy Market to Surge Significantly During the - GlobeNewswire

GlobeNewswire - Dec 01, 2025

Delaware Law Alert: Chancery Court Applies Conditional Probability to Calculate Damages in Earnout Dispute - Mayer Brown

Mayer Brown - Jun 25, 2025

Xencor Announces Change to Ultomiris® Royalty Revenue Forecast - Business Wire

Business Wire - Mar 04, 2026

Big Pharma Still Sees Value In Cell And Gene Therapy’s Next Wave - Citeline News & Insights

Citeline News & Insights - Oct 09, 2025

Acquisition of Alexion completed - AstraZeneca

AstraZeneca - Jul 21, 2021

Novartis Says Alexion's 'Block The Cause' Ads Are False - Law360

Law360 - Oct 21, 2025

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment